World Health Organisation (WHO) continues successful collaboration with Paul-Ehrlich-Institut
After eight years of successful collaboration as a "WHO Collaborating Centre for Quality Assurance of Blood Products and in vitro Diagnostic Devices" the World Health Organization (WHO) has confirmed that it will continue working with the Paul-Ehrlich-Institut (PEI) for another four years. The President of the Paul-Ehrlich Institut, Professor Klaus Cichutek, is proud that the institute is being recognised in this way: "PEI has achieved this thanks to its in-depth expertise in a wide range of areas connected with regulatory affairs and scientific research as well as its sustained and reliable support of the WHO’s activities". During his visit to the PEI on 1 July 2013, Daniel Bahr, the German Federal Minister of Health, confirmed that "The quality of the PEI's work is very highly appreciated by the WHO."
More details can be found in the PEI's press release entitled "World Health Organization (WHO) continues successful collaboration with Paul-Ehrlich-Institut".
Related GMP News
13.11.2024Warning Letter for Manufacturer of HCT/P Products
30.10.2024Warning Letter for an American Manufacturer of Blood Products
24.10.2024Supporting biopharmaceutical Research and Development for Europe
24.10.2024Revision of USP Chapter <1047> on Gene Therapy Medicinal Products
05.09.2024Revision of USP Chapter <1033> on Validation of Biological Assays published
05.09.2024Next Generation of Genome Editing?